BETA DRUGS
|
The Current P/S Ratio of BETA DRUGS is 5.61.
| Share Price | ₹2,055.2 | Sep 18,2026 |
| Market Cap | ₹2,281.3 Cr | |
| Sales-TTM | ₹407.0 Cr | TTM-Consolidated Results |
| Price/Sales | 5.61x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BETA DRUGS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,281.3 Cr] as on Sep 18,2026
(/) Sales [ ₹407.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.61x ]
Thus, for BETA DRUGS , the investors are currently willing to pay '5.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BETA DRUGS !
The chart below summarizes the trend in P/S Ratio of BETA DRUGS over the last five years.
Historical PS (Price/Sales) ratio chart of BETA DRUGS
PS Ratio Performance Analysis for BETA DRUGS
- BETA DRUGS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.18x.
- BETA DRUGS 's operated at median p/e ratio of 2.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BETA DRUGS 's p/e ratio peaked in Mar2025 at 5.31x.
- BETA DRUGS 's p/e ratio hit its five-year low in Mar2021 of 0.99x.
How does BETA DRUGS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BETA DRUGS | 407.0 | 5.61 | 2,281.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.35 | 440,398.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.14 | 248,664.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.62 | 182,738.0 |
| CIPLA LTD | 28,324.4 | 3.91 | 110,794.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.94 | 97,749.4 |
| MANKIND PHARMA LTD | 14,737.9 | 6.50 | 95,743.9 |
| LUPIN LTD | 29,966.6 | 3.27 | 98,069.8 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.02 | 115,012.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.86 | 99,828.1 |
| LAURUS LABS LTD | 7,269.6 | 14.53 | 105,645.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BETA DRUGS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.86x |
| Max industry PS | 22.14x |
| Median industry PS | 5.61x |
| Average industry PS | 7.71x |
You may also like the below Video Courses